Development
Cresco Labs Inc.
CL
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -5.51% | -9.45% | -9.19% | -9.06% | -8.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.51% | -9.45% | -9.19% | -9.06% | -8.04% |
| Cost of Revenue | -17.91% | -12.96% | 5.61% | 1.22% | 12.91% |
| Gross Profit | 5.96% | -5.33% | -23.62% | -19.81% | -21.51% |
| SG&A Expenses | -30.28% | -15.94% | -13.66% | -4.15% | 22.88% |
| Depreciation & Amortization | 65.89% | 34.56% | -23.12% | -6.13% | 34.14% |
| Other Operating Expenses | -16.47% | -- | -- | -- | 10.96% |
| Total Operating Expenses | -20.24% | -13.02% | -3.21% | -1.15% | 17.13% |
| Operating Income | 1,363.89% | 31.66% | -55.72% | -80.91% | -104.89% |
| Income Before Tax | 108.17% | -869.82% | -292.45% | -1,167.63% | -1,450.28% |
| Income Tax Expenses | -66.54% | -130.67% | -41.04% | -26.30% | 0.99% |
| Earnings from Continuing Operations | 102.70% | -3,391.69% | -423.90% | -17.47% | -1,416.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -111.58% | 67.47% | 232.11% | 147.52% | 783.66% |
| Net Income | 101.63% | -1,080.75% | -169.80% | 4.86% | -995.15% |
| EBIT | 1,363.89% | 31.66% | -55.72% | -80.91% | -104.89% |
| EBITDA | 284.66% | 23.84% | -30.86% | -50.14% | -76.37% |
| EPS Basic | 101.46% | -953.85% | -154.92% | 8.56% | -914.26% |
| Normalized Basic EPS | -51.05% | 168.78% | -52.14% | -82.83% | -33.93% |
| EPS Diluted | 101.46% | -953.85% | -154.92% | 8.56% | -914.26% |
| Normalized Diluted EPS | -51.05% | 168.78% | -52.14% | -82.83% | -33.93% |
| Average Basic Shares Outstanding | 12.15% | 12.07% | 5.84% | 4.10% | 7.88% |
| Average Diluted Shares Outstanding | 12.15% | 12.07% | 5.84% | 4.10% | 7.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |